Barbara Lupo

The genomic landscape of response to EGFR blockade in colorectal cancer

Andrea Bertotti, Eniko Papp, Siân Jones et al. · Nature · 2015 · 485 citations · Full text

Oncology, Genomic Landscape, Medicine +9

IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies

Eugenia R. Zanella, Francesco Galimi, Francesco Sassi et al. · Science Translational Medicine · 2015 · 112 citations · Full text

Tumor Biology, Marginal Response, Stable Disease +14

Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype

Barbara Lupo, Francesco Sassi, Marika Pinnelli et al. · Science Translational Medicine · 2020 · 80 citations · Full text

Tumor Biology, Gastrointestinal Oncology, Pi3k Signaling +14

The Plasma Membrane Sialidase NEU3 Regulates the Malignancy of Renal Carcinoma Cells by Controlling β1 Integrin Internalization and Recycling

Cristina Tringali, Barbara Lupo, Ilaria Silvestri et al. · Journal of Biological Chemistry · 2012 · 63 citations · Full text

Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy

Federica Cavallo, Giuseppe Milone, Dina Ben‐Yehuda et al. · Leukemia · 2011 · 61 citations

Hematological Malignancy, Lenalidomide Induction Therapy, Oncology +9